首页 › 基金 › Bastion Asset Management Inc. › PRCT
Bastion Asset Management Inc. 对 PRCT 的持仓历史
PROCEPT BIOROBOTICS CORP · 医疗保健
Bastion Asset Management Inc. 在 Q3 2026 的 13F 申报中披露持有 PRCT(PROCEPT BIOROBOTICS CORP)447,131 股,市值约 US$8.1M,约占其申报组合的 3.53%,在其申报持仓中市值排名第 13 位。 Bastion Asset Management Inc. 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-05 · 来源: SEC EDGAR Form 13F-HR
Bastion Asset Management Inc. 对 PRCT 的持仓演变
Bastion Asset Management Inc. 于 Q3 2026 首次披露 PRCT 持仓:447,131 股(约 US$8.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 447.13K | $8.09M | 新进 |
关于 PRCT 与 13F 数据
PRCT(PROCEPT BIOROBOTICS CORP)属于医疗保健行业。我们追踪的基金中还有 18 只申报持有 PRCT,申报仓位最大的包括:Soleus Capital Management, L.P. (US$22.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Bastion Asset Management Inc.
常见问题
How long has Bastion Asset Management Inc. held PRCT?
Bastion Asset Management Inc. has disclosed PRCT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Bastion Asset Management Inc.'s current position in PRCT?
As of Q3 2026, Bastion Asset Management Inc. holds 447.13K shares of PRCT (PROCEPT BIOROBOTICS CORP), valued at $8.09M, representing 3.53% of its reported portfolio and ranking #13.
Has Bastion Asset Management Inc. been buying or selling PRCT?
In the latest 13F filing (Q3 2026), Bastion Asset Management Inc. newly opened its position in PRCT.
Which other funds hold PRCT?
Other major institutional holders of PRCT include Soleus Capital Management, L.P., among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.